RE: Coverage - The Mirror12 Mar 2020 10:50
Dr Catchpole added: “If it can work on our virus, there’s no reason why it can’t work with Covid-19.”
Cathal Friel, executive chairman of Hvivo’s owner Open Orphan, added: “The company is starting the process of developing the world’s first coronavirus challenge study model – basically, we take a harmless version of the virus that we can use and monitor.
“This is a British company which is the world centre for virology.”